Barclays’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $200M | Buy |
1,556,918
+1,427,323
| +1,101% | +$183M | 0.05% | 220 |
|
|
2025
Q1 | $11.5M | Sell |
129,595
-59,532
| -31% | -$5.27M | ﹤0.01% | 941 |
|
|
2024
Q4 | $16.5M | Buy |
189,127
+17,931
| +10% | +$1.56M | ﹤0.01% | 854 |
|
|
2024
Q3 | $15.8M | Buy |
171,196
+117,993
| +222% | +$10.9M | ﹤0.01% | 828 |
|
|
2024
Q2 | $5.74M | Sell |
53,203
-12,192
| -19% | -$1.31M | ﹤0.01% | 1114 |
|
|
2024
Q1 | $6.2M | Sell |
65,395
-81,098
| -55% | -$7.69M | ﹤0.01% | 1263 |
|
|
2023
Q4 | $13.5M | Buy |
146,493
+19,948
| +16% | +$1.84M | 0.01% | 897 |
|
|
2023
Q3 | $6.36M | Buy |
126,545
+22,198
| +21% | +$1.11M | ﹤0.01% | 1026 |
|
|
2023
Q2 | $6.59M | Buy |
104,347
+2,947
| +3% | +$186K | ﹤0.01% | 1082 |
|
|
2023
Q1 | $4.56M | Sell |
101,400
-22,786
| -18% | -$1.03M | ﹤0.01% | 1134 |
|
|
2022
Q4 | $5.44M | Buy |
124,186
+50,317
| +68% | +$2.2M | ﹤0.01% | 1067 |
|
|
2022
Q3 | $4.87M | Buy |
73,869
+48,428
| +190% | +$3.19M | 0.01% | 1114 |
|
|
2022
Q2 | $1.28M | Sell |
25,441
-2,427
| -9% | -$122K | ﹤0.01% | 1893 |
|
|
2022
Q1 | $1.78M | Sell |
27,868
-44,692
| -62% | -$2.85M | ﹤0.01% | 1865 |
|
|
2021
Q4 | $7.77M | Buy |
72,560
+28,481
| +65% | +$3.05M | ﹤0.01% | 1005 |
|
|
2021
Q3 | $4.53M | Buy |
44,079
+33,272
| +308% | +$3.42M | ﹤0.01% | 1310 |
|
|
2021
Q2 | $949K | Sell |
10,807
-44,861
| -81% | -$3.94M | ﹤0.01% | 2144 |
|
|
2021
Q1 | $5.41M | Buy |
55,668
+22,901
| +70% | +$2.23M | ﹤0.01% | 1133 |
|
|
2020
Q4 | $3.68M | Sell |
32,767
-7,540
| -19% | -$846K | ﹤0.01% | 1183 |
|
|
2020
Q3 | $3.74M | Sell |
40,307
-81,943
| -67% | -$7.6M | ﹤0.01% | 1125 |
|
|
2020
Q2 | $9.54M | Buy |
122,250
+64,912
| +113% | +$5.06M | 0.01% | 679 |
|
|
2020
Q1 | $3.35M | Sell |
57,338
-51,190
| -47% | -$2.99M | ﹤0.01% | 1065 |
|
|
2019
Q4 | $8.69M | Buy |
108,528
+80,468
| +287% | +$6.45M | ﹤0.01% | 914 |
|
|
2019
Q3 | $2.06M | Sell |
28,060
-6,927
| -20% | -$509K | ﹤0.01% | 1734 |
|
|
2019
Q2 | $3.3M | Buy |
34,987
+7,208
| +26% | +$680K | ﹤0.01% | 1390 |
|
|
2019
Q1 | $2.22M | Buy |
27,779
+24,436
| +731% | +$1.96M | ﹤0.01% | 1482 |
|
|
2018
Q4 | $181K | Sell |
3,343
-27,471
| -89% | -$1.49M | ﹤0.01% | 2755 |
|
|
2018
Q3 | $2.41M | Buy |
30,814
+10,811
| +54% | +$844K | ﹤0.01% | 1634 |
|
|
2018
Q2 | $1.27M | Buy |
20,003
+7,946
| +66% | +$505K | ﹤0.01% | 1692 |
|
|
2018
Q1 | $1.11M | Buy |
12,057
+2,810
| +30% | +$258K | ﹤0.01% | 1732 |
|
|
2017
Q4 | $698K | Buy |
9,247
+6,331
| +217% | +$478K | ﹤0.01% | 1858 |
|
|
2017
Q3 | $203K | Buy |
2,916
+384
| +15% | +$26.7K | ﹤0.01% | 2385 |
|
|
2017
Q2 | $128K | Sell |
2,532
-12,923
| -84% | -$653K | ﹤0.01% | 2664 |
|
|
2017
Q1 | $618K | Buy |
15,455
+12,547
| +431% | +$502K | ﹤0.01% | 1841 |
|
|
2016
Q4 | $82K | Buy |
2,908
+2,665
| +1,097% | +$75.1K | ﹤0.01% | 2675 |
|
|
2016
Q3 | $7K | Sell |
243
-87
| -26% | -$2.51K | ﹤0.01% | 3342 |
|
|
2016
Q2 | $7K | Buy |
330
+200
| +154% | +$4.24K | ﹤0.01% | 3058 |
|
|
2016
Q1 | $2K | Sell |
130
-352
| -73% | -$5.42K | ﹤0.01% | 3198 |
|
|
2015
Q4 | $12K | Sell |
482
-191
| -28% | -$4.76K | ﹤0.01% | 2778 |
|
|
2015
Q3 | $14K | Sell |
673
-131
| -16% | -$2.73K | ﹤0.01% | 2954 |
|
|
2015
Q2 | $21K | Buy |
+804
| New | +$21K | ﹤0.01% | 2945 |
|